Health Trials

Appendix Carcinoma

2

Review clinical trials related to Appendix Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

This study seeks to learn whether using the PAGODA algorithm to guide chemotherapy dosing will lower the chance of unplanned delays during chemotherapy for cancer in the gastrointestinal system compared to usual care.

Participants needed: 420
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Alliance for Clinical Trials in OncologyUpdated: Jul 2, 2026Locations: 344
Eligibility criteria

* REGISTRATION ELIGIBILITY CRITERIA (STEP 1) [+27]

Read more
Status: Recruiting

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

To explore the safety and efficacy of Surufatinib and Sintilimab in Combination With Capecitabine in Patients With Previously Treated Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma : a Single-arm, a Single-center , Phase 2 Trial. Meanwhile, Exploring the maximum tolerant dose or recommended II research dose of Surufatinib combined with a fixed dose of Sintilimab and Capecitabine using 3 + 3 dose climbing experiment.

Participants needed: 36
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Dec 17, 2025Locations: 1
Eligibility criteria

Histological or cytological documentation of adenocarcinoma of Small Intestine o... [+7]

Prior treatment with Surufatinib [+8]

Read more